In February, CBS This Morning had a segment on Mount Sinai’s novel use of fruit flies to screen for personalized cancer drugs. Ross Cagan, PhD, Associate Dean of the Graduate School of Biomedical Sciences at Icahn School of Medicine at Mount Sinai, discussed how his laboratory replicates a patient’s tumor and implants it in a fruit fly. Then his team tests an arsenal of 840 drugs—all approved by the U.S. Food and Drug Administration for other uses—to see if they shrink the tumor.
Cancer patients with metastatic cancer, whose disease has spread to another area of the body beyond the initial site of the disease, require specialized care. At our Metastasis Center, we offer a unique approach to treating patients with metastatic cancer.
The core of our program is the personalized, concierge-style service we provide to patients. With this approach, patients can schedule an appointment to come to Mount Sinai for one day, during which a team of experts can conduct tests, review the patient’s treatment options, and provide consultation with the patient’s off-site doctors if necessary. A Clinical Nurse Navigator will work with each patient to personally tailor his or her visit and schedule all necessary appointments and tests. Remote consultations are also available.